Quick Answer
ZEVRA THERAPEUTICS, INC. reported Operating Income of -$62.94 million for fiscal year 2025.
ZEVRA THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$62.94M | +27.7% |
| 2024 | -$87.00M | -75.4% |
| 2023 | -$49.60M | -16.5% |
| 2022 | -$42.56M | -650.7% |
| 2021 | $7.73M | +237.8% |
| 2020 | -$5.61M | +72.4% |
| 2019 | -$20.34M | +63.6% |
| 2018 | -$55.90M | -67.5% |
| 2017 | -$33.37M | +11.0% |
| 2016 | -$37.48M | -64.3% |
| 2015 | -$22.81M | -38.7% |
| 2014 | -$16.44M | -248.5% |
| 2013 | -$4.72M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.14M | +115.2% | +105.8% |
| June 30, 2025 | -$71.04M | -198.5% | -1224.9% |
| March 31, 2025 | -$5.36M | +73.8% | +80.4% |
| September 30, 2024 | -$27.31M | -77.7% | -14.8% |
| June 30, 2024 | -$23.80M | -280.6% | -16.2% |
| March 31, 2024 | -$20.49M | -59.7% | -33.3% |
| September 30, 2023 | -$15.36M | -131.9% | -145.7% |
| June 30, 2023 | -$6.25M | +74.8% | +51.3% |
- ZEVRA THERAPEUTICS, INC. showed an increase of +27.7% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, ZEVRA THERAPEUTICS, INC.’s operating income has declined by 1234.1% (from -$4.72 million to -$62.94 million).
- The most recent figure is from ZEVRA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: